Anna Ractliffe
Stock Analyst at Bank of America Securities
(1.05)
# 3,729
Out of 4,579 analysts
13
Total ratings
45.5%
Success rate
-4.7%
Average return
Main Sectors:
Stocks Rated by Anna Ractliffe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €32.00 | €43.88 | -27.07% | 8 | Jul 20, 2026 | |
| EPA: BIM bioMérieux S.A. | Upgraded: Hold | €115.00 | €70.70 | +62.66% | 1 | Dec 12, 2025 | |
| LON: RS1 RS Group plc | Upgraded: Buy | 730p | 688p | n/a | 1 | May 13, 2025 | |
| BME: FDR Fluidra, S.A. | Upgraded: Buy | €21.00 → €26.00 | €18.66 | n/a | 2 | Apr 10, 2025 | |
| AMS: LIGHT Signify N.V. | Upgraded: Buy | €29.00 | €14.15 | n/a | 1 | Nov 6, 2024 |
Fresenius Medical Care AG
Jul 20, 2026
Reiterated: Sell
Price Target: €32.00
Current: €43.88
Upside: -27.07%
bioMérieux S.A.
Dec 12, 2025
Upgraded: Hold
Price Target: €115.00
Current: €70.70
Upside: +62.66%
RS Group plc
May 13, 2025
Upgraded: Buy
Price Target: 730p
Current: 688p
Upside: n/a
Fluidra, S.A.
Apr 10, 2025
Upgraded: Buy
Price Target: €21.00 → €26.00
Current: €18.66
Upside: n/a
Signify N.V.
Nov 6, 2024
Upgraded: Buy
Price Target: €29.00
Current: €14.15
Upside: n/a